نتایج جستجو برای: peptide receptor radionuclide therapy

تعداد نتایج: 1363778  

Journal: :Expert review of precision medicine and drug development 2023

Introduction Peptide Receptor Radionuclide Therapy (PRRT) is a type of molecular-targeted endo-radionuclide therapy in which unsealed radiolabelled somatostatin analogues are specifically directed toward receptors (SSTR) over-expressed Neuroendocrine Neoplasms (NEN) and related malignancies. This modality has witnessed benchmark growth over last decade symbolizes remarkable development precisio...

Journal: :iranian journal of nuclear medicine 2008
mostafa gandomkar reza najafi mohammad mazidi mostafa goudarzi seyed esmaeil sadat ebrahimi

introduction: over expression of selected peptide receptors in human tumors has been shown to represent clinically relevant targets for cancer diagnosis and therapy. the aim of this work was to investigate neuropeptide y (npy) as a new radiopharmaceutical for diagnosis of breast cancer. methods: a neuropeptide y analogues with y1 receptor preference and agonistic properties was synthesized by s...

Objective(s): Peptide Receptor Radionuclide Therapy (PRRT) with yttrium-90 (90Y) and lutetium-177 (177Lu)-labelled SST analogues are now therapy option for patients who have failed to respond to conventional medical therapy. In-house production with automated PRRT synthesis systems have clear advantages over manual methods resulting in increasing use in hospital-based radiopharmacies. We report...

Journal: :Angewandte Chemie 2022

Peptide receptor radionuclide therapy is used to treat solid tumors by locally delivering radiation. However, due nephro- and hepato-toxicity, it limited its dosage. To amplify radiation damage tumor cells, radiolabeled nanogels can be used. We show that tuning the mechanical properties of significant enhancement in circulation half-life gel could achieved. demonstrate why how small changes inf...

Journal: :Cancer Imaging 2006
Theodosia Maina Berthold Nock Stephen Mather

The fact that a number of common human tumours, including those of breast and prostate, express increased levels of the gastrin-releasing peptide receptor (GRP-R) means that this receptor is a potential target for peptide receptor mediated scintigraphy and targeted radionuclide therapy. Although clinical application is yet in its infancy, there is a considerable literature on preclinical studie...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید